Lindsey Vonn’s surgeon talks about new non-opioid treatment in road to recovery

Sean Naylor Follow

Giovanni Auletta/AP photo
When the 2026-27 Stifel US Alpine Ski Team team roster was announced earlier this month, there was one particular name that raised some questions.
While it may seem odd that there would be any speculation that one of the world’s most decorated skiers would be listed, anyone keeping up with Lindsey Vonn’s comeback would have plenty of reason to do so.
Following her harrowing crash in the Milano Cortina Olympics, many were quick to assume Vonn — who had come out of retirement last year to compete — would be done competing for sure this time.
But not so fast.
After all, the speed queen has spent more years than not on that very roster throughout this millennia. Yet, there hasn’t been any indication from Vonn — on traditional nor social media — as to whether she’d actually be competing this season.

Support Local Journalism
In October, Vail Daily spoke with Dr. Tom Hackett, Vonn’s surgeon and the chief medical officer for U.S. Ski & Snowboard, as to whether that comeback was imminent.

To little surprise, Hackett was not breaking doctor-patient privilege to share any of those indications. However, he offered a glimpse into how Vonn is doing in her recovery, which includes a new form of treatment that has been helping her along the way.
Hackett’s storied history with the team began on home turf at the Birds of Prey races in Beaver Creek before going on to various events, training camps, World Cups, World Championships, and then ultimately the Olympic Games all over the world. “Most of the time, I work as an assistant coach,” he said. “And I’m not coaching, but just running around jackets and wax supplies and stuff. I’m just embedded with the team as a helper, but then kick into place when things go south with significant injuries.”
On Feb. 8, all of that experience was called to duty as the surgeon watched Vonn’s crash unfold. “She had done exceptionally well leading up to that day, despite having had an injury,” Hackett said. “And then obviously, her crash needs no description. That was devastating to see that happen.”

Hackett’s emergency planning helped get Vonn the immediate care she needed that day. As for the road to recovery, that wouldn’t be mapped out until her return to the United States. “The injury that she had was associated with an extraordinary amount of pain,” Hackett said. “And so while we were in Italy, we leaned on whatever resources we had at the time, which were basically opioid resources and lots of them. So when we were able to come home, we talked about a non-opioid option. And that’s when we started discussing the use of this relatively new medication called JOURNAVX, which is a non-opioid medication for moderate to severe acute pain in adults. And we talked about risks and benefits, and the risk profile is extremely low, and the benefits were significant for her … Basically, it’s a medication that inhibits pain before the pain signals get to the brain. So it doesn’t affect cerebral function … it doesn’t have the same side effect profile that opioids do. And it’s worked very well for her to date,” he said.
“I’m excited for her to be able to get back to an athletic life. And I think it’s just to be determined what that will entail in terms of its scope.”
Meanwhile, Vonn has shared her progress with her fans on Instagram while keeping future aspirations open-ended.
So, while we still don’t know whether we’ll see Vonn actually compete in World Cup racing this year — her team would still need her as a manager regardless — there are indicators that her recovery has advanced enough to have such conversations. And if there’s anything we know about Vonn, it’s to not make any assumptions.
“She always had that cutting-edge, don’t-hold-back, take-no-prisoners approach to skiing, and a work ethic that is extraordinary,” Hackett said. “It’s been a pleasure to work with her and to be around that level of excellence.”








